Free Trial

Lexaria Bioscience (LEXXW) Competitors

$0.30 -0.09 (-22.64%)
As of 04/25/2025 02:33 PM Eastern

LEXXW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Lexaria Bioscience stock or one of its competitors? The main competitors of Lexaria Bioscience include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Lexaria Bioscience vs.

Lexaria Bioscience (NASDAQ:LEXXW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, profitability, community ranking, dividends, valuation and analyst recommendations.

Lexaria Bioscience and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Lexaria BioscienceN/AN/A
180 Life SciencesN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lexaria Bioscience$525.92KN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Lexaria BioscienceN/A N/A N/A
180 Life Sciences N/A N/A N/A

In the previous week, Lexaria Bioscience and Lexaria Bioscience both had 1 articles in the media. Lexaria Bioscience's average media sentiment score of 1.89 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Lexaria Bioscience Very Positive
180 Life Sciences Very Positive

Summary

Lexaria Bioscience beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get Lexaria Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for LEXXW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LEXXW vs. The Competition

MetricLexaria BioscienceBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$120.43M$5.47B$7.82B
Dividend YieldN/A3.69%5.43%4.30%
P/E RatioN/A3.0022.3718.43
Price / SalesN/A4,221.42391.12101.46
Price / CashN/A13.0238.1834.62
Price / BookN/A34.746.684.19
Net IncomeN/A-$90.45M$3.22B$248.05M
7 Day Performance-11.26%4.25%6.24%6.53%
1 Month Performance-24.58%-0.32%-2.82%-2.16%
1 Year Performance-57.51%88.86%16.46%4.71%

Lexaria Bioscience Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LEXXW
Lexaria Bioscience
N/A$0.30
-22.6%
N/A-57.5%$0.00$525,923.000.007Positive News
Gap Down
ATNFW
180 Life Sciences
N/A$0.01
-2.5%
N/A-20.0%$0.00N/A0.007Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.02
-4.5%
N/A-91.1%$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.09
+9.6%
N/AN/A$0.00$20,729.000.0040Gap Down
ALVOW
Alvotech
N/A$1.11
flat
N/A-57.2%$0.00$489.68M0.004Short Interest ↑
Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
flat
N/A-70.1%$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.05
-29.5%
N/A-23.5%$0.00$37.32M0.0070Positive News
BTMDW
biote
N/A$0.01
-2.3%
N/A-89.1%$0.00$197.19M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.08
-7.8%
N/A-86.0%$0.00N/A0.008Short Interest ↑
Gap Down
CELUW
Celularity
N/A$0.04
+5.0%
N/A+56.9%$0.00$48.20M0.00220

Related Companies and Tools


This page (NASDAQ:LEXXW) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners